Carriage of Mycoplasma pneumoniae in the Upper Respiratory Tract of Symptomatic and Asymptomatic Children: An Observational Study

PLoS Medicine

Volumn 10, Issue 5, 2013, Pages

  Spuesens, Emiel B M ^a   Fraaij, Pieter L A ^a,b   Visser, Eline G ^a   Hoogenboezem, Theo ^a   Hop, Wim C J ^b   van Adrichem, Léon N A ^b   Weber, Frank ^b   Moll, Henriette A ^a   Broekman, Berth ^c   Berger, Marjolein Y ^d   van Rijsoort Vos, Tineke ^b   van Belkum, Alex ^b,e   Schutten, Martin ^b   Pas, Suzan D ^b   Osterhaus, Albert D M E ^b   Hartwig, Nico G ^a   Vink, Cornelis ^a   van Rossum, Annemarie M C ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c General Practitioners Cooperative   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e BIOMÉRIEUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ARTICLE; ASYMPTOMATIC DISEASE; BACTERIAL COLONIZATION; BACTERIAL LOAD; CHILD; CONTROLLED STUDY; DNA ISOLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PREVALENCE; QUALITY CONTROL; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; THROAT CULTURE; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ANTIBODIES, BACTERIAL; ASYMPTOMATIC DISEASES; BACTERIOLOGICAL TECHNIQUES; CARRIER STATE; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; DNA, BACTERIAL; FEMALE; HUMANS; INFANT; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; MYCOPLASMA PNEUMONIAE; NETHERLANDS; ODDS RATIO; PNEUMONIA, MYCOPLASMA; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYSTEM; SEROLOGIC TESTS; TIME FACTORS;

EID: 84878273242     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001444     Document Type: Article

References (28)

1. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, et al. (2011) The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 53: e25-e76.
2. Harris M, Clark J, Coote N, Fletcher P, Harnden A, et al. (2011) British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax 66 (Suppl 2):: ii1-ii23.
3. Nilsson AC, Bjorkman P, Persson K, (2008) Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol 8: 93.
4. Waites KB, Talkington DF, (2004) Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 17: 697-728.
5. Ursi D, Ieven M, Noordhoek GT, Ritzler M, Zandleven H, et al. (2003) An interlaboratory comparison for the detection of Mycoplasma pneumoniae in respiratory samples by the polymerase chain reaction. J Microbiol Methods 53: 289-294.
6. Liu Y, Ye X, Zhang H, Xu X, Li W, et al. (2010) Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. Diagn Microbiol Infect Dis 67: 355-358.
7. Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, et al. (2010) High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis 51: 189-194.
8. Dorigo-Zetsma JW, Wilbrink B, van der Nat H, Bartelds AI, Heijnen ML, et al. (2001) Results of molecular detection of Mycoplasma pneumoniae among patients with acute respiratory infection and in their household contacts reveals children as human reservoirs. J Infect Dis 183: 675-678.
9. Foy HM, Grayston JT, Kenny GE, Alexander ER, McMahan R, (1966) Epidemiology of Mycoplasma pneumoniae infection in families. JAMA 197: 859-866.
10. Foy HM, Kenny GE, McMahan R, Kaiser G, Grayston JT, (1971) Mycoplasma pneumoniae in the community. Am J Epidemiol 93: 55-67.
11. Gnarpe J, Lundback A, Sundelof B, Gnarpe H, (1992) Prevalence of Mycoplasma pneumoniae in subjectively healthy individuals. Scand J Infect Dis 24: 161-164.
12. Hyde TB, Gilbert M, Schwartz SB, Zell ER, Watt JP, et al. (2001) Azithromycin prophylaxis during a hospital outbreak of Mycoplasma pneumoniae pneumonia. J Infect Dis 183: 907-912.
13. Feikin DR, Njenga MK, Bigogo G, Aura B, Aol G, et al. (2012) Etiology and incidence of viral and bacterial acute respiratory illness among older children and adults in rural western Kenya, 2007-2010. PLoS ONE 7: e43656 doi:10.1371/journal.pone.0043656.
14. Goldwater PN, Martin AJ, Ryan B, Morris S, Thompson J, et al. (1991) A survey of nosocomial respiratory viral infections in a children's hospital: occult respiratory infection in patients admitted during an epidemic season. Infect Control Hosp Epidemiol 12: 231-238.
15. Wenzel RP, Craven RB, Davies JA, Hendley JO, Hamory BH, et al. (1977) Protective efficacy of an inactivated Mycoplasma pneumoniae vaccine. J Infect Dis 136 (Suppl):: S204-S207.
16. Spuesens EB, Hoogenboezem T, Sluijter M, Hartwig NG, van Rossum AM, et al. (2010) Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing. J Microbiol Methods 82: 214-222.
17. Sluijter M, Hoogenboezem T, Hartwig NG, Vink C, (2008) The Mycoplasma pneumoniae MPN229 gene encodes a protein that selectively binds single-stranded DNA and stimulates Recombinase A-mediated DNA strand exchange. BMC Microbiol 8: 167.
18. Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, et al. (2011) Manual of clinical microbiology, 10th ed. Washington (District of Columbia): ASM Press.
19. Hoek RA, Paats MS, Pas SD, Bakker M, Hoogsteden HC, et al. (2013) Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients. Scand J Infect Dis 45: 65-69.
20. Bogaert D, van Belkum A, Sluijter M, Luijendijk A, de Groot R, et al. (2004) Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363: 1871-1872.
21. Rasmussen JN, Voldstedlund M, Andersen RL, Ellermann-Eriksen S, Jensen TG, et al. (2010) Increased incidence of Mycoplasma pneumoniae infections detected by laboratory-based surveillance in Denmark in 2010. Euro Surveill 15: 19708.
22. Maltezou HC, La-Scola B, Astra H, Constantopoulou I, Vlahou V, et al. (2004) Mycoplasma pneumoniae and Legionella pneumophila in community-acquired lower respiratory tract infections among hospitalized children: diagnosis by real time PCR. Scand J Infect Dis 36: 639-642.
23. Michelow IC, Olsen K, Lozano J, Duffy LB, McCracken GH, et al. (2004) Diagnostic utility and clinical significance of naso- and oropharyngeal samples used in a PCR assay to diagnose Mycoplasma pneumoniae infection in children with community-acquired pneumonia. J Clin Microbiol 42: 3339-3341.
24. Chanock RM, Rifkind D, Kravetz HM, Kinght V, Johnson KM, (1961) Respiratory disease in volunteers infected with Eaton agent: a preliminary report. Proc Natl Acad Sci U S A 47: 887-890.
25. Bogaert D, De Groot R, Hermans PW, (2004) Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 4: 144-154.
26. Foy HM, (1993) Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 17 (Suppl 1):: S37-S46.
27. Palma SC, Martinez TM, Salinas SM, Rojas GP, (2005) [Asymptomatic pharyngeal carriage of Mycoplasma pneumoniae in Chilean children.]. Rev Chilena Infectol 22: 247-250.
28. Kumar S, Wang L, Fan J, Kraft A, Bose ME, et al. (2008) Detection of 11 common viral and bacterial pathogens causing community-acquired pneumonia or sepsis in asymptomatic patients by using a multiplex reverse transcription-PCR assay with manual (enzyme hybridization) or automated (electronic microarray) detection. J Clin Microbiol 46: 3063-3072.